BR112022026507A2 - Processo para preparar uma formulação nanoestruturada de um ingrediente ativo lipofílico, formulação nanoestruturada, preparação farmacêutica, nutracêutica ou cosmética, e, método para tratar uma condição - Google Patents

Processo para preparar uma formulação nanoestruturada de um ingrediente ativo lipofílico, formulação nanoestruturada, preparação farmacêutica, nutracêutica ou cosmética, e, método para tratar uma condição

Info

Publication number
BR112022026507A2
BR112022026507A2 BR112022026507A BR112022026507A BR112022026507A2 BR 112022026507 A2 BR112022026507 A2 BR 112022026507A2 BR 112022026507 A BR112022026507 A BR 112022026507A BR 112022026507 A BR112022026507 A BR 112022026507A BR 112022026507 A2 BR112022026507 A2 BR 112022026507A2
Authority
BR
Brazil
Prior art keywords
nanostructured
formulation
nutraceutical
pharmaceutical
preparing
Prior art date
Application number
BR112022026507A
Other languages
English (en)
Inventor
Maretti Eleonora
Grazia Leo Eliana
Brighenti Virginia
Original Assignee
Performs S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Performs S R L filed Critical Performs S R L
Publication of BR112022026507A2 publication Critical patent/BR112022026507A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCESSO PARA PREPARAR UMA FORMULAÇÃO NANOESTRUTURADA DE UM INGREDIENTE ATIVO LIPOFÍLICO, FORMULAÇÃO NANOESTRUTURADA, PREPARAÇÃO FARMACÊUTICA, NUTRACÊUTICA OU COSMÉTICA, USO DE UMA SUSPENSÃO NANOESTRUTURADA, E, MÉTODO PARA TRATAR UMA CONDIÇÃO. A presente invenção refere-se a uma plataforma tecnológica para a entrega de ingredientes ativos lipofílicos.
BR112022026507A 2020-07-07 2021-07-07 Processo para preparar uma formulação nanoestruturada de um ingrediente ativo lipofílico, formulação nanoestruturada, preparação farmacêutica, nutracêutica ou cosmética, e, método para tratar uma condição BR112022026507A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000016411A IT202000016411A1 (it) 2020-07-07 2020-07-07 Formulazione per veicolare principi attivi lipofili
PCT/IB2021/056096 WO2022009118A1 (en) 2020-07-07 2021-07-07 Formulation to deliver lipophilic active ingredients

Publications (1)

Publication Number Publication Date
BR112022026507A2 true BR112022026507A2 (pt) 2023-01-31

Family

ID=72709644

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022026507A BR112022026507A2 (pt) 2020-07-07 2021-07-07 Processo para preparar uma formulação nanoestruturada de um ingrediente ativo lipofílico, formulação nanoestruturada, preparação farmacêutica, nutracêutica ou cosmética, e, método para tratar uma condição

Country Status (11)

Country Link
US (1) US20230255893A1 (pt)
EP (1) EP4178552A1 (pt)
JP (1) JP2023533777A (pt)
CN (1) CN116209427A (pt)
AU (1) AU2021305974A1 (pt)
BR (1) BR112022026507A2 (pt)
CA (1) CA3184499A1 (pt)
IL (1) IL299199A (pt)
IT (1) IT202000016411A1 (pt)
MX (1) MX2023000441A (pt)
WO (1) WO2022009118A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102014868B (zh) * 2008-04-28 2014-11-12 莫尼科贾夫西尔瓦诺21控股股份公司 含有棕榈酰乙醇酰胺和硬脂酰乙醇酰胺的药物制剂
US9328060B2 (en) * 2013-10-18 2016-05-03 East Carolina University J-series prostaglandin-ethanolamides as novel therapeutics
CN108451905B (zh) * 2018-05-31 2020-04-07 中国人民解放军陆军军医大学 一种藤黄酸纳米乳制剂及其制备方法和应用

Also Published As

Publication number Publication date
IL299199A (en) 2023-02-01
IT202000016411A1 (it) 2022-01-07
CA3184499A1 (en) 2022-01-13
MX2023000441A (es) 2023-02-09
AU2021305974A1 (en) 2023-01-19
US20230255893A1 (en) 2023-08-17
EP4178552A1 (en) 2023-05-17
WO2022009118A1 (en) 2022-01-13
CN116209427A (zh) 2023-06-02
JP2023533777A (ja) 2023-08-04

Similar Documents

Publication Publication Date Title
Flores et al. Hydrogels containing nanocapsules and nanoemulsions of tea tree oil provide antiedematogenic effect and improved skin wound healing
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
BR112014028633A8 (pt) tratamento de amd usando sflt-1 de aav
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
EA201991299A1 (ru) Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов
BR112022008000A2 (pt) Derivado de pirazol-heteroarila, método de preparação para o mesmo e uso médico do mesmo
EA022847B1 (ru) Дезинфицирующий и антисептический препарат, имеющий сниженное содержание йода
CN109789179A (zh) 具有抗真菌活性的局部应用的组合物
WO2019011955A3 (de) Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff
EP3852760A4 (en) MATTER ON THE COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF THE ANALOGUES DERIVED FROM FL118 PLATFORM POSITIONS 7 AND 9 FOR THE TREATMENT OF HUMAN DISEASES
WO2020079489A3 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
BR112022026507A2 (pt) Processo para preparar uma formulação nanoestruturada de um ingrediente ativo lipofílico, formulação nanoestruturada, preparação farmacêutica, nutracêutica ou cosmética, e, método para tratar uma condição
WO2018229093A8 (en) NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE PRINCIPLES AND METHODS OF PRODUCING SAME
CY1116245T1 (el) Φαρμακευτικη συνθεση η οποια εχει αντιμικροβιακη και ταχεια επουλωτικη δραστικοτητα για εξωτερικη χορηγηση, και διεργασια για την παρασκευη αυτης
BR112022010340A2 (pt) Composições farmacêuticas
WO2020016655A3 (en) Treatment of neuropathy with dna constructs expressing igf-1 isoforms
BR112021000183A8 (pt) Preparação medicinal para uso externo
BR112023018932A2 (pt) Formulação para administração ocular, recipiente de dosagem, uso de uma formulação, e, método para o tratamento de um transtorno ocular
CL2019000123A1 (es) Preparaciones de vitaminas que contienen galato de propilo.
JP2020158493A (ja) パンテノールを含有する油中水型（ｗ／ｏ型）クリーム
BR112022008357A2 (pt) Composições e métodos para a distribuição de canabinoides à pele
BR112018005922A2 (pt) ingrediente farmacêutico ativo e seu uso, composição de creme regenerador de epiderme e cicatrizante epidérmico, composição de creme nutritivo epitelial e para tratar psoríase, composição de gel cicatrizante em aerossol, composição líquida nasal e composição de sabão líquido
CR20220620A (es) Composición farmacéutica acuosa de levilimab y su uso
Pariser et al. Efficacy and safety of onychomycosis treatments: an evidence-based overview
EP3189837A1 (en) Use of flavonoid compound in preparation of composition for healing wound